Human Rabies --- Michigan, 2009

Human Rabies --- Michigan, 2009
Weekly
April 15, 2011 / 60(14);437-440




On November 9, 2009, a Michigan hospital informed CDC of suspected rabies in a man aged 55 years. The patient reportedly had awakened with a bat on his arm 9 months earlier but had not sought medical evaluation. He went to a local emergency department (ED) on October 30 and soon after was hospitalized; he died 12 days later. On November 14, CDC confirmed infection with a rabies virus variant that commonly infects the silver-haired bat (Lasionycteris noctivagans) (Figure). This report summarizes the patient's clinical course and the associated public health investigation. The report highlights the importance of public awareness of rabies, particularly among persons who might be at risk for wildlife exposures. Persons who experience contact with a bat and cannot confidently rule out a bite or scratch should seek prompt medical attention.

Case Report

On October 30, the man went to a local ED after 10 days of pain and progressive numbness in the left hand and arm and pain in his lower neck and upper back. The patient had sought treatment for these symptoms from a chiropractor several times during the preceding 6 days. Although the back pain had improved, the numbness and tingling had worsened, and he was experiencing weakness in his left hand and arm. A neurologic examination revealed normal strength and sensation of his lower extremities. His right arm showed normal strength, but the left hand showed no grip, and the patient could only lift his left arm a few inches. The patient was afebrile, and his blood pressure was normal when he arrived at the ED. A complete blood count and routine chemistries were normal except for an elevated white blood cell count of 15,300/µL (normal: 3,600--10,000/µL) and elevated glucose of 155 mg/dL (normal: 70--99 mg/dL). A computed tomography scan of the brain without contrast revealed a cavernous sinus larger on the left than on the right and an area of slightly decreased density in the right basal ganglion and paraventricular areas.

During the ED evaluation, the patient's breathing became labored, and he had difficulty with respiratory secretions. He was placed on ventilation and transferred to a nearby tertiary-care facility. At the time of intubation, the anesthesiologist noted that the procedure was easy to perform because of lack of muscle tone in the patient's pharynx.

On admission to the tertiary-care facility, respiratory failure secondary to cerebral vascular accident or acute idiopathic demyelinating polyradiculoneuropathy (AIDP or Guillain-Barré syndrome) were the chief diagnoses considered. Findings from magnetic resonance imaging were unremarkable. Electromyography showed mild decreased conduction velocities and multiple absent F waves. Thereafter, AIDP was suspected, and intravenous immunoglobulin therapy was begun. The patient's sedation was lightened to conduct physical examinations.

During the first 2 days of hospitalization, the patient experienced progressive weakness, initially on the left side. He was able to respond to verbal commands and, according to the neurologist who evaluated him, his random eye movements were normal. On November 1, the patient's mental status appeared to improve, as sedation was lightened with the hope of removing him from the ventilator. However, over the next few days, his upper extremity weakness progressed to involve the right side, and lower extremity weakness was noted, demonstrating areflexia and a lack of response to plantar stimulation. Some nystagmus on far horizontal gaze to either side also was noted as a new development. On November 3, the patient became quadriplegic but could move his eyes to the right and left on request. Analysis of his cerebrospinal fluid (CSF) revealed several abnormal values: protein of 109 mg/dL (normal: 10--55 mg/dL); glucose of 92 mg/dL (normal: 45--75 mg/dL); and a white blood cell count of 243 cells/µL (normal: <5 cells/µL) with a differential of 80% lymphocytes, 18% monocytes, and 2% segmented neutrophils. A Gram stain and culture were negative. On November 4, the patient had an acute change in his neurologic status, including twitching of the left foot, more marked nystagmus, and slightly asymmetric pupils. Based on the results of the CSF analysis, the working diagnosis was changed to meningoencephalitis, and an infectious disease consultation was sought. The CSF was further analyzed for Borrelia burgdoferi and the following viruses: West Nile, St. Louis encephalitis, California Group, Eastern equine encephalitis, Western equine encephalitis, measles, mumps, herpes simplex virus 1 and 2, enteroviruses, varicella-zoster, cytomegalovirus, lymphocytic choriomeningitis virus, adenovirus, and influenza. All tests were negative. Antiviral treatment with acyclovir was begun. The patient's electroencephalogram showed marked deterioration from previous studies, indicating severe encephalopathy. On November 4, the infectious disease physician asked the patient's wife about any animal exposure history. The couple lived in a rural area. In the past, the patient had trapped wildlife for pelts and raised orphaned animals, but he had not engaged in these activities in the past year. The wife had no knowledge of any recent animal bites the patient might have received. On November 8, another relative recounted an incident that had occurred approximately 9 months before onset of illness. The patient had told the relative about waking one night to a bat crawling on his arm. The relative did not know whether the patient had been bitten by the bat. The bat had been killed and discarded, and the patient did not seek medical care for the incident. The patient's condition, characterized as complete flaccid paralysis, coma, and flat electroencephalogram, remained unchanged. On November 11, the patient's family elected to withdraw life support, and the patient died shortly afterward. Public Health Investigation After obtaining the bat exposure history, the infectious disease physician contacted CDC on November 9 to discuss a diagnosis of rabies. The Michigan Department of Community Health Bureau of Laboratories also was contacted by the hospital regarding specimen collection. Serum, CSF, saliva, and nuchal skin biopsy specimens were collected and sent to CDC on November 10. On November 12, CDC reported detecting no rabies virus antigens in the skin biopsy by direct fluorescent antibody test, nor amplicons in the saliva or skin biopsy specimens by reverse transcription--polymerase chain reaction. However, rabies virus antibodies were detected by indirect fluorescent antibody test and rapid fluorescent focus inhibition tests on serum and CSF. Both health-care facilities involved in the patient's care were informed of the results, as well as the local health departments covering those jurisdictions. The patient's family was informed and gave permission for a brain autopsy. On November 13, brain specimens were collected and shipped overnight to CDC. On November 14, CDC reported that rabies virus antigens were detected in the brain by direct fluorescent antibody test. Sequence analysis of the nucleoprotein gene was consistent with a rabies virus variant found in L. noctivagans in the United States. A total of 14 family members and friends were interviewed by the local health department regarding exposure to the patient's saliva during the 2 weeks before his illness onset and during his hospitalization. Eleven family members received rabies postexposure prophylaxis (PEP) at the advice of the local health department because of possible exposure to saliva through shared glasses or cups; an additional person also received PEP, although it was not recommended. Of 180 health-care providers from the two health-care facilities who were assessed for potential exposure to rabies virus based on their likelihood of saliva contact, six received rabies PEP. Reported by
K Signs, DVM, MG Stobierski, DVM, Michigan Dept of Community Health. CE Rupprecht, VMD, PhD, Div of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases; K Robertson, DVM,* EIS Officer, CDC. *Corresponding contributor: Kis L. Robertson, CDC, 410-767-0202, krobertson@cdc.gov.

full-text (large):
Human Rabies --- Michigan, 2009